Budesonide Nasal Dosage
This dosage information may not include all the information needed to use Budesonide Nasal safely and effectively. See additional information for Budesonide Nasal.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Allergic Rhinitis
Nasal aerosol:
2 sprays (32 mcg/spray) in each nostril in the morning and evening or 4 sprays in each nostril in the morning. Maximum recommended dose is 8 sprays (256 mcg)/day.
Nasal Spray:
1 spray (32 mcg) in each nostril once daily. Maximum dose: 4 sprays (128 mcg) in each nostril once daily.
Usual Pediatric Dose for Allergic Rhinitis
6 years or older:
Nasal aerosol: 2 sprays (32 mcg/spray) in each nostril in the morning and evening or
4 sprays in each nostril in the morning. Maximum recommended dose is 8 sprays (256 mcg)/day.
Nasal spray: 1 spray (32 mcg) in each nostril once daily. Maximum dose: less than 12 years: 2 sprays (64 mcg) in each nostril once daily; 12 years or older: 4 sprays (128 mcg) in each nostril once daily.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
In patients with perennial allergic rhinitis, once adequate relief has been obtained the dose should be gradually decreased every 2 to 4 weeks as long as the desired clinical effect is maintained. If symptoms return, the dose may briefly be increased to the patient's starting dose and then returned to the dose the patient was on before symptoms reoccurred.
Precautions
Intranasal corticosteroids may cause a reduction in growth velocity in pediatric patients. The growth of should be routinely monitored. Each patient should be titrated to the lowest dose that effectively controls his or her symptoms.
Dialysis
Data not available
Other Comments
A decrease in symptoms may occur as soon as 24 hours after onset of treatment but generally it takes 3 to 7 days to reach maximum benefit. If no improvement has been obtained by the third week of treatment, the nasal inhaler treatment should be discontinued.
